Auranofin. New oral gold compound for treatment of rheumatoid arthritis.
Eight patients with rheumatoid arthritis were treated with SK & F D-39162 (auranofin), a new oral gold compound which was effective in suppressing adjuvant-induced arthritis in rats. Clinical and humoral parameters were studied during a 3-month period of drug administration followed by a 3-month per...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1976
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1006549/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/791161/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.35.3.251 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|